• 2008

Company Description

CerRx engages in the discovery and development of anticancer drugs such as Fenretinide and Safingol.

CerRx Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide, a synthetic molecule that increases ceramide waxes and kills cancer cells; and Safingol, an artificial ceramide precursor that increases killing of fenretinide in cancer cells. The company was founded in 2008 and is based in Lubbock, Texas.